MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2

Completed

Conditions: Stage I Small Lymphocytic Lymphoma
Stage II Chronic Lymphocytic Leukemia
Stage III Small Lymphocytic Lymphoma
Stage IV Chronic Lymphocytic Leukemia
Stage 0 Chronic Lymphocytic Leukemia
Stage I Chronic Lymphocytic Leukemia
Stage II Small Lymphocytic Lymphoma
Stage III Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Stage IV Small Lymphocytic Lymphoma

Interventions: Drug: Cyclophosphamide
Other: Laboratory Biomarker Analysis
Biological: Ofatumumab
Drug: Pentostatin

First Posted Date: 2009-12-02

Last Posted Date: 2018-09-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 82

Registration Number: NCT01024010

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 1 locations

Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2009-12-02

Last Posted Date: 2012-04-18

Lead Sponsor: Mayo Clinic

Registration Number: NCT01024114

Locations: 🇺🇸
Mayo Clinic - Rochester, Rochester, Minnesota, United States

"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"

Phase 4

Completed

Conditions: Dementia With Lewy Bodies

Interventions: Drug: Armodafinil

First Posted Date: 2009-12-02

Last Posted Date: 2013-09-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT01023672

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer

Completed

Conditions: Neoadjuvant Therapy
Chemotherapy
Hormone Replacement Therapy
Breast Cancer

First Posted Date: 2009-12-02

Last Posted Date: 2013-05-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT01023802

Locations: 🇺🇸
Mayo Clinic - Rochester, Rochester, Minnesota, United States

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

Completed

Conditions: Coronary Artery Disease
Diabetes Mellitus Type 2

Interventions: Drug: Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere

First Posted Date: 2009-11-30

Last Posted Date: 2015-07-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 33

Registration Number: NCT01021865

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction

Phase 2

Completed

Conditions: Tobacco Dependence

Interventions: Drug: nicotine lozenges
Drug: tobacco-free snuff

First Posted Date: 2009-11-23

Last Posted Date: 2013-09-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 81

Registration Number: NCT01018394

Locations: 🇺🇸
Oregon Research Institute, Eugene, Oregon, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer

Not Applicable

Completed

Conditions: Pancreatic Cancer

Interventions: Procedure: EGD with EUS
Device: 4D-ELF

First Posted Date: 2009-11-18

Last Posted Date: 2014-07-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 37

Registration Number: NCT01015820

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States

Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation

Not Applicable

Completed

Conditions: Smoking

Interventions: Behavioral: Informing surgical patients about CO monitoring
Behavioral: a brief intervention recommending preoperative abstinence from smoking

First Posted Date: 2009-11-17

Last Posted Date: 2011-08-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 169

Registration Number: NCT01014455

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Does Zumba Improve Cognition in Healthy APOE e4 Carriers and Noncarriers

Not Applicable

Completed

Conditions: Cognitive Impairment

Interventions: Other: Zumba exercise

First Posted Date: 2009-11-13

Last Posted Date: 2012-05-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 65

Registration Number: NCT01012791

Locations: 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States

Evaluation of a Biofeedback-assisted Meditation Program as a Stress Management Tool for Hospital Nurses

Not Applicable

Completed

Conditions: Stress

Interventions: Behavioral: Healing Rhythms™ Meditation Program

First Posted Date: 2009-11-11

Last Posted Date: 2012-02-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 11

Registration Number: NCT01011790

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy